Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 2Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Surgical Wound Infection 1Postoperative Complications 1Neoplasms 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neomycin × Clear all
NCT03856671 2023-04-05

Prophylatic Effect Preoperative Antibiotics With Mechanical Bowel Preparation in SSIs

Third Affiliated Hospital, Sun Yat-Sen University

Phase NA Completed
309 enrolled
Gastrointestinal

Postoperative Complications, Surgical Wound Infection, Colorectal Neoplasms

NCT02001909 2015-08-13

Effect of Neomycin on the Pharmacokinetics of Regorafenib

Bayer

Phase 1 Completed
27 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡